Keyphrases
Advances in Management
11%
Allograft
11%
Allograft Loss
11%
B Cells
11%
B-lineage
11%
Cellular Origin
11%
Current Therapeutics
11%
Disease Losses
11%
Epstein-Barr Virus
11%
Epstein-Barr Virus-positive
11%
Event-free Survival
11%
Gastrointestinal Tract
11%
Graft Loss
11%
Heart Transplant
11%
Heart Transplant Recipients
11%
Histology
11%
Large Group
11%
Lymphoproliferative Disorders
100%
Multi-institutional Study
100%
Organ Transplantation
11%
Outcome Mortality
11%
Pediatric Heart Transplant
100%
Post-transplant Lymphoproliferative Disorder
100%
Probability of Freedom
22%
Progressive Disease
11%
Respiratory System
11%
Risk Factors for Survival
11%
Site of Disease
11%
Survival Probability
11%
Therapeutic Approaches
11%
Therapeutic Outcome
11%
Transplant Experiment
11%
Transplant Recipients
11%
Unsatisfactory Outcome
11%
Medicine and Dentistry
Allograft
22%
B Cell
22%
Cell Lineage
11%
Disease
11%
Epstein Barr Virus
22%
Event Free Survival
11%
Gastrointestinal Tract
11%
Graft Failure
11%
Heart Graft
33%
Heart Transplantation
100%
Lymphoproliferative Disease
100%
Organ Transplantation
11%
Pediatrics
100%
Posttransplant Lymphoproliferative Disease
100%
Prevalence
11%
Progressive Disease
11%
Respiratory System
11%
Transplantation
11%
Immunology and Microbiology
Allotransplantation
15%
B Cell
15%
Cell Lineage
7%
Epstein Barr Virus
15%
Event Free Survival
7%
Gastrointestinal Tract
7%
Heart Transplantation
100%
Lymphoproliferative Disorders
100%
Organ Transplantation
7%
Prevalence
7%
Respiratory System
7%
Transplant Procedure
100%